Navellier & Associates Inc Merck & Co., Inc. Transaction History

Navellier & Associates Inc

  • $705 Million
  • Q3 2024

A detailed history of Navellier & Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Navellier & Associates Inc holds 12,718 shares of MRK stock, worth $1.25 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
12,718
Previous 15,479 17.84%
Holding current value
$1.25 Million
Previous $1.92 Million 24.63%
% of portfolio
0.2%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$111.15 - $128.97 $306,885 - $356,086
-2,761 Reduced 17.84%
12,718 $1.44 Million
Q2 2024

Aug 08, 2024
SELL
$123.8 - $132.96 $10,646 - $11,434
-86 Reduced 0.55%
15,479 $1.92 Million
Q1 2024

May 13, 2024
SELL
$113.24 - $131.95 $104,294 - $121,525
-921 Reduced 5.59%
15,565 $2.05 Million
Q4 2023

Feb 08, 2024
BUY
$100.18 - $109.02 $276,096 - $300,459
2,756 Added 20.07%
16,486 $1.8 Million
Q3 2023

Nov 09, 2023
BUY
$102.95 - $114.33 $411,182 - $456,634
3,994 Added 41.02%
13,730 $1.41 Million
Q2 2023

Aug 07, 2023
BUY
$108.61 - $118.38 $41,489 - $45,221
382 Added 4.08%
9,736 $1.12 Million
Q1 2023

May 12, 2023
SELL
$102.94 - $114.86 $112,101 - $125,082
-1,089 Reduced 10.43%
9,354 $995,000
Q4 2022

Feb 02, 2023
BUY
$87.44 - $112.11 $45,119 - $57,848
516 Added 5.2%
10,443 $1.16 Million
Q3 2022

Nov 09, 2022
SELL
$84.53 - $94.96 $39,729 - $44,631
-470 Reduced 4.52%
9,927 $855,000
Q2 2022

Aug 12, 2022
BUY
$83.49 - $94.64 $8,265 - $9,369
99 Added 0.96%
10,397 $948,000
Q1 2022

Apr 29, 2022
SELL
$73.51 - $82.4 $9,335 - $10,464
-127 Reduced 1.22%
10,298 $845,000
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $40,621 - $50,883
-562 Reduced 5.12%
10,425 $799,000
Q3 2021

Oct 28, 2021
SELL
$71.68 - $78.83 $38,420 - $42,252
-536 Reduced 4.65%
10,987 $825,000
Q2 2021

Aug 09, 2021
SELL
$70.31 - $77.77 $12,163 - $13,454
-173 Reduced 1.48%
11,523 $896,000
Q1 2021

May 12, 2021
SELL
$68.86 - $81.11 $51,231 - $60,345
-744 Reduced 5.98%
11,696 $902,000
Q4 2020

Feb 05, 2021
SELL
$71.77 - $79.65 $30,645 - $34,010
-427 Reduced 3.32%
12,440 $1.02 Million
Q3 2020

Nov 09, 2020
SELL
$73.18 - $82.95 $92,938 - $105,346
-1,270 Reduced 8.98%
12,867 $1.07 Million
Q2 2020

Aug 12, 2020
BUY
$70.42 - $80.13 $734,128 - $835,355
10,425 Added 280.85%
14,137 $1.09 Million
Q1 2020

May 13, 2020
SELL
$63.36 - $87.82 $319,968 - $443,490
-5,050 Reduced 57.64%
3,712 $286,000
Q4 2019

Feb 12, 2020
BUY
$77.58 - $87.54 $19,395 - $21,885
250 Added 2.94%
8,762 $797,000
Q3 2019

Oct 16, 2019
SELL
$76.08 - $82.93 $7,075 - $7,712
-93 Reduced 1.08%
8,512 $717,000
Q2 2019

Jul 17, 2019
SELL
$69.84 - $81.59 $28,145 - $32,880
-403 Reduced 4.47%
8,605 $722,000
Q1 2019

May 15, 2019
SELL
$69.58 - $79.36 $20,456 - $23,331
-294 Reduced 3.16%
9,008 $749,000
Q4 2018

Jan 15, 2019
BUY
$65.24 - $75.71 $306,628 - $355,836
4,700 Added 102.13%
9,302 $711,000
Q3 2018

Nov 14, 2018
SELL
$57.69 - $67.84 $432,617 - $508,732
-7,499 Reduced 61.97%
4,602 $326,000
Q2 2018

Aug 06, 2018
SELL
$50.83 - $59.72 $55,862 - $65,632
-1,099 Reduced 8.33%
12,101 $735,000
Q1 2018

May 21, 2018
SELL
$50.96 - $59.23 $110,838 - $128,825
-2,175 Reduced 14.15%
13,200 $719,000
Q4 2017

Feb 12, 2018
SELL
$51.62 - $61.64 $1.63 Million - $1.95 Million
-31,600 Reduced 67.27%
15,375 $865,000
Q3 2017

Nov 14, 2017
SELL
$58.67 - $63.13 $605,239 - $651,249
-10,316 Reduced 18.01%
46,975 $3.01 Million
Q2 2017

Aug 24, 2017
BUY
N/A
57,291
57,291 $3.67 Million

Others Institutions Holding MRK

# of Institutions
3,828
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email